WXIBF News and Press, Wuxi Biologics Cayman Inc From 07/05/22

WuXi Biologics ( OTCPK:WXXWY ) ( OTCPK:WXIBF ) gained nearly 12% on Tuesday after Reuters reported that the Wuxi, China-based life sciences company is one step closer to getting off the U.S. Commerce Department's "Unverified List." According to a department official, C...

We had previously owned WuXi Biologic shares but sold it in the second quarter of 2019. We bought back WXIBF stock after a sharp price correction in the first quarter of 2021. The rapid development of several antibody drugs for COVID-19 gave a further, unexpected boost to WuXi...

Harding Loevner has been investing globally in high-quality, growing businesses based on disciplined industry research since 1989. Stock markets fell in the quarter, as the world watched in horror Russia’s invasion of Ukraine. China-based WuXi Biologics illustrates the perf...

Vir Biotechnology (NASDAQ:VIR) announced on Friday that its Chinese partner WuXi Biologics (OTCPK:WXXWY) (OTCPK:WXIBF) ended its partnership for development and manufacturing for several of company’s antibody drugs including the COVID-19 antibody therapy sotrovimab. Per the terms of th...

Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron New Asia Fund (the “Fund”) declined 15.24% (Institutional Shares) during the first quarter of 2022. ...

China’s leading biotechnology and other health care companies have continued to grow revenues rapidly over the past two years and are expected to see strong growth in the years to come. Recently, concerns over domestic regulation, increased domestic competition, US Food and Dru...

The ADRs of Shanghai-based I-Mab (NASDAQ:IMAB) jumped ~18% in the pre-market Wednesday after Bloomberg reported that the clinical-stage biotech company was considering options including a potential sale amid takeover interest from other global drugmakers. I-Mab (IMAB) has lost more ...

On Feb. 15, institutional investment managers with more than $100 million AUM had to disclose their positions at the end of Q4 2021. I curated a list of some of the best-performing hedge funds and looked into their holdings at the end of December 2021. This list is particularly ti...

Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affiliated Managers Group. The Glob...

The pharmaceutical market reached a total value of US$1.27 trillion in 2020, according to data from Statista , up significantly from US$887 billion in 2010. By 2025, that value is expected to increase even further to an estimated US$1.6 billion. Experienced and novice invest...